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A B S T R A C T
Reactions of glutathione (GSH) with O,O-diorganyl dithiophosphoric acids (DTPA) were studied to develop
bioactive derivatives of GSH. Eﬀective coupling reaction of GSH with DTPA was proposed to produce the am-
monium dithiophosphates (GSH–DTPA) between the NH2 group in γ-glutamyl residue of GSH and the SH group
in DTPA. A series of the GSH–DTPA salts based on O-alkyl or O-monoterpenyl substituted DTPA were synthe-
sized. Enhanced radical scavenging activity of the GSH–DTPA over GSH was established with the use of DPPH
assay and improved ﬂuorescent assay which utilizes Co/H2O2 Fenton-like reaction. Similarly to GSH, the di-
thiophosphates induced both pro- and antioxidant eﬀects in vitro attributed to diﬀerent cellular availability of
the compounds. Whereas extracellularly applied GSH greatly stimulated proliferation of cancer cells (PC-3,
vinblastine-resistant MCF-7 cells), the GSH–DTPA exhibited antiproliferative activity, which was pronounced for
the O-menthyl and O-isopinocampheolyl substituted compounds 3d and 3e (IC50≥ 1 μM). Our results show that
the GSH–DTPA are promising redox modulating and antiproliferative compounds. The approach proposed can
be extended to modiﬁcation and improvement of bioactivity of various natural and synthetic peptides.
1. Introduction
L-γ-Glutamyl-L-cysteinyl-glycine (glutathione, GSH) is the pre-
vailing antioxidant oligopeptide in mammals, which plays a crucial role
in non-speciﬁc and enzyme-assisted defense of living cells from oxygen
radicals, detoxiﬁcation of xenobiotics, maintenance and regulation of
the redox homeostasis in cells [1–4].
The association of GSH deﬁciency with a variety of human meta-
bolic, degenerative, aging-related diseases [4] and viral infection [3] is
well established. At the same time, elevated GSH level is often involved
in tumor resistance and progression [5]. GSH, its analogues and me-
tabolizing enzymes attract considerable interest in biomedical and
pharmacological research. Most enzymes of the GSH metabolism, e.g.
catalyzing biosynthesis of GSH (γ-glutamyl transferase), nucleophilic
addition reactions of the thiol group (glutathione-S-transferase), me-
thylglyoxal detoxiﬁcation (glyoxalase) and redox reactions (glutathione
reductase, glutathione peroxidase) are established pharmacother-
apeutic targets [1,6].
A number of synthetic approaches to developing enzyme eﬀectors
based on the tripeptide GSH have been proposed to date. Main strate-
gies for generation of the bioactive analogues and derivatives of GSH,
summarized by Lucente et al. [1], include replacement of one or more
amino acids in the tripeptide backbone with artiﬁcial analogues (D-, N-
methyl-, α-methyl-glutamic acid, α-methyl-L-cysteine, β-alanine) as
well as modiﬁcation of the SH group of cysteine in order to produce
both reversible and irreversible inhibitors of GSH-metabolizing en-
zymes (see [1] and references within). Some other approaches in GSH
chemistry proposed are aimed at the GSH derivatives with increased
biological stability, e.g. resistance to blood γ-glutamyl transpeptidase,
by means of esteriﬁcation of the carboxyl functions [6] and cyclization
of the GSH molecule [1].
Burg and Mulder summarized the state of the art in developing
derivatives and analogues of GSH with antiproliferative activity and
studying their capacity to overcome cancer drug resistance associated
with GSH-dependent enzymes [6]. These enzymes are glutathione S-
transferases catalyzing GSH conjugation to harmful electrophilic com-
pounds, including carcinogens and anticancer drugs, DNA-dependent
protein kinase (PI 3-kinase family) involved in repairing double-strand
breaks in DNA as well as glyoxalase system (glyoxalases I and II) par-
ticipating in elimination of cytotoxic α-oxoaldehydes [6]. Some ex-
amples of eﬀective inhibitors of these enzymes include S-alkyl deriva-
tives of γ-glutamyl-2-aminoadipic acid analogue, GSH derivatives
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